Cart
Orders
Not available here
Product Overview
Replengen Fine with Lidocaine is a cross-linked hyaluronic acid dermal filler manufactured by Reanzen Co., Ltd. Its published formulation contains HA 24 mg/mL and lidocaine 3 mg/mL. This page compares Fine with the documented Deep and Volume formulations for professional buyers. The comparison distinguishes manufacturer-published specifications from historical packaging information, helping buyers check the formulation and exact presentation against the supplied product label before selecting an option.
Key Features
- Cross-linked HA: Fine and Deep have a manufacturer-published hyaluronic acid concentration of 24 mg/mL.
- Lidocaine-containing formulations: Fine and Deep are listed with lidocaine 3 mg/mL.
- Product-specific origin: The manufacturer declares South Korea as the country of origin for Fine and Deep.
Composition & Specifications
| Specification | Published information |
|---|---|
| Product category | Cross-linked hyaluronic acid dermal filler |
| Manufacturer | Reanzen Co., Ltd. |
| Principal ingredients | Cross-linked hyaluronic acid 24 mg/mL; lidocaine 3 mg/mL |
| Country of origin | South Korea |
| Documented presentation | 1.1 mL per syringe; one syringe per carton in the 2019 manufacturer specification |
The documented presentation is not confirmation of the current supplied pack or its accessories. Check the exact product label and package contents.
How the Ingredients Work
Hyaluronic acid gels bind water and provide a filling effect. Cross-linking can prolong the persistence of an HA gel. Lidocaine is a local anesthetic included in some dermal fillers to reduce procedure-related discomfort. These are general ingredient properties, not evidence of a particular Replengen treatment outcome, duration or comparative performance.
Replengen Variant Comparison
Fine and Deep have manufacturer-published ingredient specifications. The Volume formulation below is documented in a 2019 manufacturer brochure and should be checked against current labeling. Equal ingredient concentrations do not establish that variants have identical gel properties or are interchangeable.
| Variant | Cross-linked HA | Lidocaine | Specification qualification |
|---|---|---|---|
| Replengen Fine | 24 mg/mL | 3 mg/mL | Manufacturer-published formulation |
| Replengen Deep | 24 mg/mL | 3 mg/mL | Manufacturer-published formulation |
| Replengen Volume | 24 mg/mL | Lidocaine HCl 3 mg/mL | Historical 2019 manufacturer specification; confirm current label |
| Replengen Implants | Not publicly verified | Not publicly verified | Exact product identity requires confirmation before comparison |
The 2019 specification describes Fine, Deep and Volume with lidocaine as monophasic gels, each presented in a 1.1 mL syringe with one syringe per carton. Current packaging and included accessories must be checked separately.
Storage & Handling
Follow the storage conditions and expiry date on the supplied product label and market-specific instructions for use. Confirm these details for the exact variant and package revision rather than applying a historical family specification to current stock.
Dermal filler use is a medical procedure requiring an appropriately qualified healthcare professional. Serious complications can occur, including vascular injury, blindness and stroke. Product eligibility, permitted indications and purchasing restrictions depend on the destination market; this page does not establish local authorization.
Frequently Asked Questions
Does the same HA concentration make Fine, Deep and Volume equivalent?
No. The documented formulations share an HA concentration of 24 mg/mL, but concentration alone does not establish equivalent gel properties or suitability. Assess the exact variant using its current labeling and instructions for use.
Is the 1.1 mL presentation a multi-syringe pack?
The historical manufacturer specification lists one 1.1 mL syringe per carton for Fine, Deep and Volume with lidocaine. Check the current supplied pack separately, including any accessories.
What should professional buyers confirm before selecting a variant?
Confirm the exact model name, lidocaine formulation, package contents, expiry date, storage instructions and destination-market eligibility. The Implants option requires exact product identification before formulation specifications can be assigned.